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Introduction / objectives
Use and overuse of antibiotics are among the main driv-
ing factors for the emergence of antimicrobial resistance
(AMR). However, oncology patients often require pro-
longed administration of broad spectrum antimicrobials.
Methods
A literature search was performed through PubMed
from 1 January 2006 to 31 December 2010 to identify
review papers, international guidelines, and standardised
protocols for infection prophylaxis and therapy in oncol-
ogy patients. Keywords used were: “cancer”, “infection”,
“febrile neutropenia”, and “antimicrobial resistance”.
Results
The search yielded 309 papers; 60 were selected accord-
ing to the above-mentioned criteria. The main gaps
identified in all retrieved papers were: limited relevance
of both updated local patterns of AMR and antimicro-
bial pharmacokinetics and pharmacodynamics; and no
integration with infection control policies to prevent
transmission of multidrug-resistant organisms (MDRO).
Monitoring and feedback of AMR data are not only the
hallmark of infection control — they are also necessary
to tailor subsequent empirical regimens; pharmacoki-
netics and pharmacodynamics can optimize drug choice
and daily dosing, according to the target site of infec-
tion. Although antimicrobial stewardship programmes
(ASP) are recognized as effective tools to optimize anti-
microbial usage, tackle AMR, and improve clinical out-
comes on an institutional basis, none has been
implemented in oncology settings as yet, and the con-
cept itself of ASP is lacking for this patient population.
Conclusion
Oncology patients would benefit from a multidisciplin-
ary approach integrating local AMR patterns, pharmaco-
kinetics and pharmacodynamics, strict infection control
policies, and reliable diagnosis through novel technolo-
gies. At last, they should not be excluded from the
assets that targeted interventions provided by ASP can
offer.
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